King Pharmaceuticals is a publicly traded company trading on XNYS, led by CEO Bradford Luke Ledbetter, with a market cap of $87.2M.
Common questions about King Pharmaceuticals
King Pharmaceuticals (KG) has a market capitalization of $87.2M and trades on XNYS.